C-Reactive Protein to Albumin Ratio Versus Coronary Artery Ectasia as Predictors of No-reflow After

The aim of this study was to evaluate and compare the importance of the C-reactive protein Albumin ratio (CAR) versus coronary artery ectasia (CAE) as predictors of no-reflow phenomenon.

Methods: This study looked at 90 ST segment elevation myocardial infarction patients who were treated with primary percutaneous coronary intervention (PPCI) within 24 hours of presenting at Tanta University Hospitals in Gharbia Governorate, Egypt. This is a prospective research, and data collection began in June 2018 and lasted for 12 months. The post-primary PCI thrombolysis in myocardial infarction (TIMI) flow score was used to classify patients into two classes. Patients in Group I (Case group) had no-reflow phenomenon TIMI 0-1 flow after primary PCI. TIMI flow 2 after primary PCI in Group II (Control group). They underwent a thorough clinical review, as well as laboratory tests such as CRP and serum albumin, as well as a 12-lead surface ECG, echocardiography, and primary percutaneous coronary intervention (PCI).

Results: There was a significant statistical difference between the two groups in terms of age (60 years, 96.7 percent vs 20%, P 0.001), gender (male, 93.3 percent vs 63.3 percent, P = 0.002), ischemia time (100 percent vs 33.3 percent, P > 0.001), CRP level (64 32.6 mg/L vs 26.27 21.5 mg/L, P > 0.001), serum albumin (3.22 0.23 g/ In terms of smoking, dyslipidemia, and revascularization process, however, there was no statistically significant difference between the two classes.

Conclusion: In acute STEMI patients managed by primary PCI within 24 hours of presentation, CAR is more important and accurate than CAE in predicting no reflow.

Please see the link :- https://www.journaljammr.com/index.php/JAMMR/article/view/30687